ToxGenSolutions is a diagnostic start-up focusing on the development of innovative preclinical diagnostic methods for a selection of high-impact chronic pathologies, with Alzheimer's Disease as our hallmark. Early detection of brain pathology, by transferring epi-genetic biomarkers into fast, cheap, and minimally invasive biomedical devices allowing preclinical diagnosis. AI and computational approaches allow identification of new drug targets and preventive drugs.
ToxGenSolutions is a diagnostic start-up focusing on the development of innovative preclinical diagnostic methods for a selection of high-impact chronic pathologies, with Alzheimer's Disease as our hallmark. Early detection of brain pathology, by transferring epi-genetic biomarkers into fast, cheap, and minimally invasive biomedical devices allowing preclinical diagnosis. AI and computational approaches allow identification of new drug targets and preventive drugs.
Your career starts on Magnet.me
Create a profile and receive connection requests from interested companies.
ToxGenSolutions is dedicated to create a better future for patients that suffer from a multitude of chronic diseases. This does not only include therapeutic solutions, but frequently starts with an optimized diagnostic approach with which medical intervention can be applied earlier in a patient's medical journey, leading to more optimal results. It is better to prevent a disease, than to…
ToxGenSolutions is dedicated to create a better future for patients that suffer from a multitude of chronic diseases. This does not only include therapeutic solutions, but frequently starts with an optimized diagnostic approach with which medical intervention can be applied earlier in a patient's medical journey, leading to more optimal results. It is better to prevent a disease, than to cure it.
We also work towards personalized medicine. Whereas science is starting to take individual differences into account, we rarely see diversification based on biological sex. Certain diseases, including Alzheimer's, are more frequently diagnosed in women while clinical studies performed on therapies for these diseases are more often than not performed on white men, leading to effectivity hurdles in translation. Biological reasoning for why these differences occur could severely benefit therapies to be developed, somewhere ToxGenSolutions aims to be frontrunner in.
ToxGenSolutions is dedicated to create a better future for patients that suffer from a multitude of chronic diseases. This does not only include therapeutic solutions, but frequently starts with an optimized diagnostic approach with which medical intervention can be applied earlier in a patient's medical journey, leading to more optimal results. It is better to prevent a disease, than to cure it.
We also work towards personalized medicine. Whereas science is starting to take individual differences into account, we rarely see diversification based on biological sex. Certain diseases, including Alzheimer's, are more frequently diagnosed in women while clinical studies performed on therapies for these diseases are more often than not performed on white men, leading to effectivity hurdles in translation. Biological reasoning for why these differences occur could severely benefit therapies to be developed, somewhere ToxGenSolutions aims to be frontrunner in.
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.